NEW YORK, March 12 (Reuters) - A federal appeals court

on Tuesday revived a lawsuit by a whistleblower who accused

McKesson of providing drug pricing tools to doctors to

induce them to purchase drugs from the company.

The decision by the 2nd U.S. Circuit Court of Appeals in

Manhattan restores claims by Adam Hart, a former McKesson

business development executive.

(Reporting by Jonathan Stempel in New York)